| Literature DB >> 35566061 |
Yuqiong Song1,2,3, Shengjun Chen1,2, Laihao Li1,2, Yaoxun Zeng4, Xiao Hu1,2,5.
Abstract
Skin hyperpigmentation resulting from excessive tyrosinase expression has long been a problem for beauty lovers, which has not yet been completely solved. Although researchers are working on finding effective tyrosinase inhibitors, most of them are restricted, due to cell mutation and cytotoxicity. Therefore, functional foods are developing rapidly for their good biocompatibility. Food-derived peptides have been proven to display excellent anti-tyrosinase activity, and the mechanisms involved mainly include inhibition of oxidation, occupation of tyrosinase's bioactive site and regulation of related gene expression. For anti-oxidation, peptides can interrupt the oxidative reactions catalyzed by tyrosinase or activate an enzyme system, including SOD, CAT, and GSH-Px to scavenge free radicals that stimulate tyrosinase. In addition, researchers predict that peptides probably occupy the site of the substrate by chelating with copper ions or combining with surrounding amino acid residues, ultimately inhibiting the catalytic activity of tyrosinase. More importantly, peptides reduce the tyrosinase expression content, primarily through the cAMP/PKA/CREB pathway, with PI3K/AKT/GSK3β, MEK/ERK/MITF and p38 MAPK/CREB/MITF as side pathways. The objective of this overview is to recap three main mechanisms for peptides to inhibit tyrosinase and the emerging bioinformatic technologies used in developing new inhibitors.Entities:
Keywords: bioactive peptides; hyperpigmentation; mechanism; molecular docking; tyrosinase activity
Mesh:
Substances:
Year: 2022 PMID: 35566061 PMCID: PMC9103514 DOI: 10.3390/molecules27092710
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
The sources of food-derived tyrosinase inhibitory peptides (TIPs) and their activity.
| Origin | Source | Peptides Sequences or Hydrolysates | Molecular Weight (Da) | Acitivity Evaluation | References |
|---|---|---|---|---|---|
| Terrestrial origin | Potato | Solunum tuberosum peels hydrolysates | 485,980 | 990.44 μg KE/μg peptides | [ |
| Vicia faba pods | Broad bean pods hydrolysates | 26,102 | 135.80 μg KE/μg peptides | [ | |
| Chinese | RHAKF | 658 | IC50: 0.93 mg/mL | [ | |
| Defatted | FPY | 425 | IC50: 1.11 mmol/L | [ | |
| Liquid | LQPSHY | 744 | IC50: 0.16 mmol/L | [ | |
| Rice starch | Strain hydrolysates | <1000 | 107.70 mgKAeq/g | [ | |
| Chicken | Proteolysates | <3000 | IC50: 0.04 µg/mL | [ | |
| Egg white | IRW | 340 | IC50: 2.90 mmol/L | [ | |
| Egg white | GYSLGNWVCAAK | 1268 | IC50: 3.04 mmol/L | [ | |
| Milk | MHIR | 555.30 | IC50: 0.08 mmol/L | [ | |
| Camel milk | αS-casein hydrolysates | >10,000 | 0.2 mg/mL (peptides): 39.26% | [ | |
| Ganoderma lucidum | VLT | 639 | 5.0 mg/mL (peptides): 16.00% | [ | |
| Porcine skin | Proteolysates | <3000 | 5.0 mg/mL (peptides): 69.80% | [ | |
| Chia seeds | Proteolysates | <3000 | IC50: 0.66 mg/mL | [ | |
| Sorghum | Proteolysates | <1000 | Peptides solution: 14.20% | [ | |
| Aquatic origin | Rhopilema hispidum | Collagen hydrolysates | <10,000 | Collagen solution: 64.00% | [ |
| Sea cucumber | Body wall gelatin | 700–1700 | 0.1 mg/mL (peptides): 30.80% | [ | |
| Grass carp fish | FTGML | 567 | IC50: 1.89 mmol/L | [ | |
| Mackerel meat | VWWW | 680 | IC50: 1.25 mmol/L | [ | |
| Tuna (backbone protein) | VKAGFAWTANQQLS | 1519 | IC50: 0.60 mmol/L | [ | |
| Milk fish scale | MSCP | / | IC50: 0.75 mg/mL | [ | |
| Bigeye tuna | Proteolysates | 50,000–100,000; | 5.0 mg/mL: | [ | |
| Zebrafish | Phosvitin-derived peptide Pt5 | / | 0.1 mg/mL (peptides): 16.00% | [ |
Figure 1Anti-tyrosinase mechanisms of food-derived tyrosinase inhibitory peptides (TIPs) by anti-oxidation.
Figure 2Simulated conjugation between food-derived tyrosinase inhibitory peptides (TIPs) and tyrosinase by molecular docking.
Interactive forces and amino acid residues between TIPs and tyrosinase.
| Peptide Sequences | Tyrosinase | Interaction Forces and Residues | References |
|---|---|---|---|
| IQSPHFF | IC50: 1.70 mmol/L | Hydrogen bond: Lys229, Gly250, Ser276 | [ |
| π–π stacking: His266 | |||
| FTGML | IC50: 1.89 mmol/L | Hydrogen bond: Lys147, Trp53 | [ |
| π–π stacking: Trp53 | |||
| π–Alkyl: Ile39, Phe41 | |||
| Attractive Charge: Asp51 | |||
| NGVQPKY | / | Hydrogen bond: Asn260, His94, His296 | [ |
| π–π stacking: His263 | |||
| π–Alkyl: Val283 | |||
| CNGVQPK | / | Hydrogen bond: Pro277, Leu275, Gly281, Gly257 | [ |
| π–Alkyl: Asn260, Glu256, Met257 | |||
| IR | / | Hydrogen bond: His85, His94, Glu256, His259, Asn260, His263, Gly281, His296 | [ |
| π–Alkyl: His244, His263 | |||
| Alkyl: Val283, Ala286 | |||
| LK | / | Hydrogen bond: His61, His85, Glu256, His259, His263, Met280, His296 | [ |
| π–Alkyl: His244, His263 | |||
| π–Amide stacking: His244, His263 | |||
| Alkyl: Val283, Ala286 | |||
| VY | / | Hydrogen bond: His85, His263, Gly281, His296 | [ |
| π–π stacking: His263 | |||
| π–Alkyl: His85 | |||
| Alkyl: Val283 | |||
| π–Sigma: Val283 | |||
| π–Amide stacking: His85 | |||
| GYSLGNWVCAAK | IC50: 3.04 mmol/L | Hydrogen bond: Tyr65, His259, His263, Arg268, Gly281, Glu322 | [ |
| Hydrophobic Interaction: Ala80, Cys83, Arg321, His85, Val283, Asn81, | |||
| Glu189, His244, Val248, Asn260, Phe264, Ala323 | |||
| Covalent bond: CuB | |||
| ECGYF | IC50: 0.46 mmol/L | Hydrogen bond: Met280, Tyr65, Asn260, His263 | [ |
| Hydrophobic interaction: Phe264, Pro284 | |||
| FPY | IC50: 3.22 mmol/L | Hydrogen bond: Asn260, Pro81 | [ |
| π–π stacking: Ser282, His263 | |||
| π–Alkyl: Ala286, Val283 | |||
| π–Sigma: Val283 | |||
| π–Cation: His259 | |||
| RHAKF | IC50: 1.15 mg/mL | Hydrogen bond: Gln351, Asp336, Ile96, Gln74, His76 | [ |
| Donor–Donor interaction: Gln74 | |||
| π–Alkyl: Ile328 | |||
| π–Cation: Lys5 |
Figure 3Possible tyrosinase signaling pathways in melanocytes. P is a symble of phosphoryla tion. α and βγ belong to the subunits of G-protein coupled receptors (GPCRs).